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Abstract
This chapter summarizes the progress in Escherichia coli research that used the 
 meta-analysis approach. Using systematic searches for E. coli literature, we tracked 
meta-analysis publications and analyzed them based on a number of parameters. These 
included subject/topic (epidemiology, clinical/intervention/prevention and environmen-
tal), geographical region (the Americas, Europe and Australasia) and clinical syndrome 
(enteric, renal, and sepsis/meningitis). These parameters were plotted in terms of time 
span to obtain a sense of dynamic change or its absence through the years since the turn 
of the twentieth century. In terms of region, topic and syndrome, highest meta-analysis 
productivity was attributed to the Americas, clinical/intervention/prevention and enteric, 
all of which took place in the last 5 years (2011–2016). Over the combined time span of 
16 years, the Americas significantly dominated meta-analysis outputs when compared 
to Europe and Australasia (P = 0.003). In conclusion, our findings facilitate awareness of 
the progress in this field wherein the studied parameters were analyzed for patterns over 
time and differential rates of publication productivity.
Keywords: Escherichia coli, meta-analysis
1. Introduction
Published researches on Escherichia coli (E. coli) have increased in number since the turn of 
the twentieth century. A search of E. coli publications in PubMed reveals an output value of 
339,415 (as of July 16, 2016) which when narrowed to E. coli in title only, the number is still 
 substantial (96,594). Majority of the E. coli publications are primary studies which when address-
ing the same issue, most often produce contradictory results [1]. Thus when primary studies are 
reviewed (usually in the narrative style), these contradictions hinder meaningful integration of 
results. A more systematic way to integrate primary study findings is the use of meta-analysis.
© 2017 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
1.1. Meta-analysis defined
Meta-analysis is defined as a statistical analysis of primary study results for the purpose 
of integrating the findings into a summary effect [2]. Considered at the top of the hierar-
chy of evidence [3], it is a logically formal and objective technique as well as quantitative 
mode of summarizing research findings in order to identify genuine associations [1, 4]. 
Meta-analysis is categorized under the rubric of a systematic review, a process that entails 
gathering all  completed published studies from the primary literature specific to a targeted 
research  question [5]. Meta-analysis opens the possibility to accurately estimate the overall 
outcome measure, with increased statistical power, than is possible using only a single study 
[6]. Historical application of meta-analysis in E. coli research is relatively extensive as it has 
addressed key research questions. These include epidemiology, prevention, intervention 
issues and  environmental concerns.
1.2. Importance of meta-analysis
The importance of meta-analysis is best appreciated when compared to the primary study. 
First, meta-analysis is cheaper, but not necessarily easier to do. Primary studies on the other 
hand are more expensive and logistically problematic, especially when large [1, 7]. Second, 
primary studies often do not have enough statistical power to assess relationships between 
risks (interventions) and outcomes. Being most useful when individual studies are too 
small to yield valid conclusions, meta-analysis increases power, reduces risk of error and 
facilitates exploratory analysis to generate hypotheses for future research [8]. The reason for 
 performing a meta-analysis has to do with sample sizes of the studies, when they are large 
but results conflict, or when they are small, but their positive findings are not consistent [9]. 
The  meta-analysis approach enables its findings to unmask large-scale patterns not obvious 
in primary studies [10, 11]. This then results in greater statistical precision meriting higher 
confidence. Thus, meta-analysis findings facilitate more efficient transfer of knowledge from 
researcher to clinician enabling analyses of important patient subgroups, delineation of high 
risk factors for infection enough for information to be useful for public health advice in risk 
for infection. Consequently, meta-analysis lends rigor to better assist health authorities in 
directing therapeutic decisions to target populations, urgency for health education and con-
trol measures [1]. Indeed, in the public health domain, a number of difficult issues that had 
been repeatedly studied were either resolved or clarified by the application of meta-analysis 
techniques [12]. This has led some government guidelines to recommend meta-analysis as the 
preferred method of summarizing evidence of effectiveness and safety of health technologies 
in the face of multiple study results [13].
1.3. Performing meta-analysis
1.3.1. Literature search and data abstraction
A publishable meta-analysis should have enough primary studies that address a common 
topic. The published Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
(PRISMA) statement recommends that a full electronic search strategy for at least one major 
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database be presented [14], although such an approach is considered insufficient by some 
[15]. Still a typical search strategy should involve electronic retrieval of all available  literature, 
which includes databases such as PubMed using Medline (http://www.ncbi.nlm.nih.gov/
pubmed), ScienceDirect (www.sciencedirect.com), Institute of Scientific Information (ISI) 
Web of Knowledge (http://www.isiwebofknowledge.com) and Google Scholar (http://scholar.
google.com). For greater precision in this step, additional measures to exhaustively identify 
eligible studies include manual searching of relevant journals, references lists and personal 
contact with researchers.
1.3.2. Summary effect analysis
Meta-analyses report findings in terms of effect sizes, which provide information about the 
magnitude of change. The forest plot typifies presentation of meta-analysis results, which are 
generated by software such as Stata®, Review Manager and Comprehensive Meta-analysis®. 
The forest plot example [16] in Figure 1 was generated from Review Manager (Cochrane 
Collaboration, Oxford, England). The plot is composed of five columns, the leftmost with 
qualitative data (study, named by last name of first author) and the remaining four with 
quantitative data. Between columns three and four is the actual forest plot with a solid verti-
cal line (labeled 1 on the x-axis) which corresponds to the null effect. The area to the left of the 
vertical line indicates decreased risk and to its right increased risk. The two leftmost  columns 
show the raw data (cases/controls) from which the odds ratios (OR) and 95%  confidence 
 intervals (CI) (rightmost column) are calculated. The OR and 95% CI express the study-specific 
 findings (there are 18 of them), and a single summary effect that systematically combines the 
18 ORs. Significance of the study-specific and summary effects is visually determined when 
Figure 1. Forest plot for the overall effect of EAEC on acute diarrhea among South-Asian children [16]. EAEC: 
enteroaggregative E. coli; n: affected number; N: total number; OR: odds ratio; CI: confidence interval; df: degree of 
freedom; I2: measure of variability between studies; P: P value.
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the lines associated with the squares and the diamond (♦) touch the vertical line (labeled 1). 
If the vertical line is touched, the interpretation is non-significant, otherwise it is significant. 
Numerically, each 95% CI, expressed as decimal, will either pass 1 (non-significant) or not 
(significant). For significance of the summary effect (♦), this is also determined by the tests 
generated by the software, results of which are found at the bottom left of the forest plot. The 
test for overall effect, represented here by the Z-test and its corresponding P value, is 0.008 
indicating significance. This graph has been much more explained in detail in two previous 
papers [1, 16].
1.3.3. Modifier analyses
Standard meta-analysis comprises a set of features that include a summary effect (expressed 
in various types of statistical metrics). Not being the endpoint, the summary or pooled 
effect needs to be tested further to ensure rigor of this methodology. An armory of statistical 
 techniques is available to test the stability of this effect. These techniques include subgroup, 
outlier and sensitivity analyses, collectively known as modifiers. First, modifier analysis could 
take the forms of subgrouping by categories such as geography, gender and ethnicity. From 
these categories, one could delineate similar or contrasting effects between the subgroups, 
along with the precision or lack of it as indicated by the CI. Second, pooled effects could be 
influenced by outlying studies, and these are determined by the Galbraith plot method [17]. 
Omission of such studies followed by re-analysis generates one of the two results affecting the 
original pooled effect: (i) unaltered, indicating stability and (ii) altered in terms of direction of 
association which indicates instability. In addition, outlier treatment could affect heterogene-
ity (see below). Finally, summary effects are tested for robustness with sensitivity analysis 
wherein the studies are serially omitted followed by recalculation to determine deviation or 
resistance of the pooled effect from the original [18].
1.4. Biases in meta-analysis
Despite the appeal of meta-analysis, it is only as good as the studies used to create it  dependent 
on the experience of the researcher performing it [19]. As in primary studies, meta-analysis 
is not immune to biases, but the good thing about these limitations is its transparency in 
admitting their presence. Furthermore, the meta-analysis protocol contains inherent statisti-
cal mechanisms to adjust and minimize these biases.
1.4.1. Heterogeneity
Heterogeneity in a broad sense involves clinical, methodological, biological and epidemio-
logical issues and is often topic specific [20]. In this section, we examine statistical heterogene-
ity, which in the meta-analytical context, is defined as statistical dissimilarity across various 
studies [1]. Adjusting for heterogeneity involves appropriate use of analysis models. This 
involves use of the random-effects model [2], which assumes variability across populations 
usually resulting in a wider CI [21]. However, when component studies in a meta-analysis are 
similar to each other, this indicates absence of heterogeneity; then, the fixed-effects method of 
analysis [22] is applied based on the assumption that associations are the same across studies 
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and  recognizing that the collection of eligible literature is not heterogeneous. Heterogeneity 
is statistically estimated using a chi-square–based Q test [23] and quantified with the I2 met-
ric, which shows what proportion of the total variation across studies is beyond chance [24]. 
Values of I2 lie between 0 and 100% where a value >75% may be considered  substantially het-
erogeneous [24]. Heterogeneous results warrant investigation into its sources, either through 
meta-regression [25] or outlier treatment [17]. The former focuses on covariates and the latter 
is graphically assessed with the Galbraith plot [17], which is used to detect outlying studies. 
Exclusion of outliers followed by recalculation either reduces or removes heterogeneity of the 
original findings.
1.4.2. Publication bias
Publication bias [26] occurs when significant findings receive priority in published literature 
over those whose results are non-significant [18]. This bias is evaluated graphically with the 
funnel plot (Figure 2A). The points with small studies scattered along the length of the x-axis 
but still centered on the OR estimates from large, more precise studies. This figure shows a 
symmetrical distribution indicating absence of bias. In contrast, Figure 2B shows a simulated 
funnel plot indicating presence of publication bias, which shows an asymmetrical distribution 
of the points [1]. The subjectivity in interpreting the funnel plot is overcome with  objective 
statistical tests for publication bias, the Egger’s regression asymmetry [21] and Begg’s and 
Mazumdar’s rank correlation [27] tests.
1.5. Escherichia coli
In this section, we discuss E. coli studies as is relevant to the topics addressed by meta-analysis. 
Meta-analyses have covered E. coli topics that included environmental factors such as water 
quality, clinical aspects, which include intervention/prevention approaches and epidemiolog-
ical issues which address prevalence factors. E. coli is the predominant facultative anaerobe of 
the human colonic flora that inhabit the gastrointestinal tracts of humans and warm-blooded 
Figure 2. Funnel plot showing absence (A) and presence (B) of publication bias [1]. EAEC: enteroaggregative E. coli; 
SE: standard error; (B) is a simulated funnel plot [1].
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animals, as well as one of the most important pathogens [28]. Occupying the mucous layer of 
the mammalian colon, E. coli colonizes this area in infants within hours of life, and thereafter, 
it usually remains harmlessly confined to the intestinal lumen [29]. As  commensal, E. coli 
lives in a mutually beneficial association with hosts and rarely causes disease. Thus, E. coli is 
part of the protective microbial community in the intestine and is essential for general health. 
The conditions where E. coli strains cause disease are among  immunocompromised hosts 
or where the normal gastrointestinal barriers are violated [30]. Infections due to pathogenic 
E. coli may be limited to the mucosal surfaces or can disseminate throughout the body. This 
spread throughout the body includes the digestive, renal and nervous systems [28, 29, 31]. We 
use these systems appear in our survey of meta-analysis publications on E. coli to track the 
evolvement and progress in this field.
1.6. Methods used in the survey
To obtain a sense of outputs in E. coli meta-analyses, we performed a systematic search of 
meta-analysis publications using the keywords, “meta-analysis” and “E. coli” in PubMed 
using Medline, Google Scholar and Science Direct in the title/abstract box. If the title did 
not explicitly indicate the above keywords, we read the abstracts and/or full-text article to 
determine its study design. Nevertheless, we excluded systematic reviews without the meta-
analysis aspect in the article. For articles to be included, meta-analysis and/or E. coli should 
be in the title. If only meta-analysis was in the title, we read the text to determine if the role 
of E. coli was central or marginal. Central role meant that E. coli was the focus of the paper. If 
E. coli was among the foci of the paper, findings for E. coli should be statistically significant. 
If otherwise, the paper was relegated to marginal status. We defined marginal as E. coli being 
grouped with other bacteria and/or that E. coli findings were non-significant or unassociated 
with the outcome.
Figure 3 is a flowchart of our literature search of meta-analyses on E. coli. Of the 202 citations, 
130 were excluded because they were not meta-analyses nor reviews nor about E. coli. In addi-
tion, many were duplicates of those already found in PubMed. Of the remaining 72 records, 
45 had E. coli and/or meta-analysis in the title and the other 27 did not. These 27 were then 
assessed further by reading the full text from which we excluded 14 marginal papers leaving 
13 central articles for inclusion in the analysis. These 13 with the 45 titled papers gave a total 
of 58 articles which we evaluated based on three parameters: (i) subject [epidemiology (EPI), 
clinical intervention/prevention (CIP), and environmental (ENV)]; (ii) time span (2000–2004, 
2005–2010 and 2011–2016) and (iii) region (the Americas, Europe and Australasia). The num-
ber of publications was assessed using these parameters. Of the 58 papers, 15 articles could 
not be categorized into clinical syndromes because they addressed unrelated issues such as 
water, sanitizing and contamination. The remaining 43 papers were categorized by syndrome 
wherein the articles were either enteric (ENT), renal (REN), sepsis (SEP) or a combination 
of these three (MUL for multiple). From these parameters, we generated publication output 
rates in the following plots: (i) topic spread through time (Figure 4); (ii) topic standardized 
by number of countries per region through time (Figure 5); (iii) region through time wherein 
both were standardized by the number of countries per region (Figure 6) and number of years 
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per time span (Figure 7), respectively and (iv) clinical syndrome wherein both were standard-
ized by the number of countries per region (Figure 8) and number of years per time span 
(Figure 9), respectively. Visual differences between the parameters were further analyzed 
statistically.
Figure 3. Flowchart of selection of studies for inclusion in the systematic survey.
Evaluating Meta-Analysis Research of Escherichia coli
http://dx.doi.org/10.5772/67337
235
Figure 4. Meta-analysis publication outputs in E. coli research by topic. ENV: environmental; EPI: epidemiological; CIP: 
clinical/intervention/prevention.
Figure 5. Meta-analysis publication outputs in E. coli research of three major world regions categorized by topic. 
Values in the Y-axis indicate number of meta-analyses divided by the number of countries per region. Numbers in 
parentheses indicate number of countries comprising the region; ENV: environmental; EPI: epidemiological; CIP: 
clinical/intervention/prevention.
Escherichia coli - Recent Advances on Physiology, Pathogenesis and Biotechnological Applications236
Figure 6. Meta-analysis publication outputs in E. coli research standardized by the number of countries per region. 
Numbers in parentheses indicate number of countries comprising the region.
Figure 7. Meta-analysis publication outputs in E. coli research standardized by the number of years per time span. 
Numbers in parentheses indicate number of countries comprising the region.
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2. Main body
2.1. Review of E. coli meta-analyses based on topics
E. coli is responsible for a good number of hospital-acquired and community-acquired infec-
tions more than any other single bacterial species. In a wider context, it is responsible for a 
great deal of infant morbidity and mortality due to its action as a pathogen in the bowel [32]. 
Figure 8. Meta-analysis publication outputs in E. coli research by clinical syndrome standardized by the number of 
countries per region. Numbers in parentheses indicate number of countries comprising the region; MUL: multiple; SEP: 
sepsis; REN: renal; ENT: enteric.
Figure 9. Meta-analysis publication outputs in E. coli research by clinical syndrome standardized by the number of years 
per time span. MUL: multiple; SEP: sepsis; REN: renal; ENT: enteric.
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Studies of E. coli in the ENV context have not been well undertaken compared to CIP stud-
ies. ENV studies of this pathogen in the meta-analysis context have involved water, which 
addressed quality [33, 34], contamination [35] and treatment issues [36]. Yet, the importance 
of this environmental factor related to E. coli pathogenicity is relevant to particular regions 
of the world especially the developing countries. Fecal pollution of natural waters has been 
increasingly important, and the consequences of discharge of untreated sewage into river 
estuaries and the sea have been extensively studied [32]. To a lesser degree, soil research 
has been undertaken to a magnitude that warranted meta-analysis treatment [37]. In general, 
strategies for prevention and control of the spread of E. coli should include access to safe 
water, good handling practices to reduce the risk of food contamination, sanitation measures, 
public education and vaccination [38, 39]. E. coli in the context of epidemiology as approached 
from a meta-analysis perspective involves prevalence issues [40, 41] and reviews epidemic 
potential [42, 43] of this pathogen as well as being a causative factor in diarrheal illness [44]. 
Given the variety of epidemiological areas of E. coli research warranting meta-analysis, it 
provides a fertile base of future undertakings in this area. Clinical topics addressed with the 
meta-analysis approach vary depending on subjects involved. These topics provide a sense of 
the number of primary studies in areas such as infection, treatment and prevention.
2.2. Review of E. coli meta-analyses based on clinical syndromes
Enteric/diarrheal diseases involve intestinal pathogens that are spread through the fecal-oral 
route by ingestion of contaminated food or water [45]. These pathogens termed diarrheagenic 
E. coli (DEC) are differentiated, among others, on the basis of distinct clinical and pathogenic 
features (pathotypes) [29]. The five pathotypes of DEC are enterotoxigenic E. coli (ETEC), 
enteropathogenic E. coli (EPEC), enteroaggregative E. coli (EAEC), enterohemorrhagic E. coli 
(EHEC) and enteroinvasive E. coli (EIEC). In addition, Shiga Toxin-producing E. coli (STEC) 
are foodborne pathogens that cause human infections acquired through fecal-oral contact 
with contaminated human and animal feces [46]. Urinary tract infection (UTI) is the most 
common extra-intestinal E. coli infection caused by uropathogenic E. coli which when iso-
lated, the condition generally responds rapidly to antibiotic therapy. Sequelae from UTI could 
complicate pregnancy and target pre-school age children rendering the possibility of chronic 
renal damage [32]. Related to the renal system is verocytotoxin-producing E. coli (VTEC) 
 infection, which could result in hemolytic uremic syndrome; this occurs in up to 15% of cases 
[47]. An increasingly common cause of extra-intestinal infections is the pathotype responsible 
for meningitis and sepsis/meningitis-associated E. coli [32]. The included meta-analyses here 
addressed issues with E. coli strains such as STEC, VTEC, ETEC and EAEC [16, 40, 44, 47–51]. 
Two of these strains were addressed with antibiotics [47, 49]. Resistance to antibiotics was the 
subject of five studies [52–56]. Associations of antibiotics with infection were addressed in 
seven articles [57–63]. The topics of E. coli associations with water were addressed in 10 papers 
[33–37, 64–69]. There were three papers on E. coli shedding in cattle [70–72]. Immunology 
topics were the focus in three papers [73–75]. Although most meta-analyses included here 
addressed enteric E. coli infections, there are papers that addressed renal infections [53, 54, 
76] with a fairly good number of E. coli meta-analyses and UTI performed in various contexts 
such as epidemiology [42, 55], intervention [52, 54] and prevention [73]. Meta-analyses of 
E. coli in the context of sepsis/meningitis have so far been confined to mice and infants [58, 77].
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2.3. E. coli meta-analyses involving non-human animals and plants
Our collection of E. coli meta-analyses involved non-human animals and plants, mainly farm 
animals. These included poultry [78], cattle [41, 69–72, 79–81] and pigs [61, 82]. Non-farm 
animals where E. coli studies have been meta-analyzed were mice [77]. Farmed non-animals 
where E. coli research has been meta-analyzed included fresh-produce studies [68, 83]. E. coli 
infection among pets and wild animals has produced primary studies [32] but not enough of 
their numbers warranted meta-analysis.
2.4. Assessing E. coli meta-analyses by topic
Figure 4 shows the results of E. coli meta-analysis productivity in span of 16 years (grouped 
into three time spans) and across three topics. Between 2000 and 2004, CIP outputs dominated 
those of EPI and ENV, but between 2005 and 2010, outputs from all three topics were more 
or less similar. Between 2011 and 2016, CIP outputs dwarfed those of the other two, although 
EPI outputs were slightly more than those of ENV. The combined data of 16 years between 
the topics showed non-significant higher CIP outputs than EPI and ENV [one-way analysis of 
variance (ANOVA): P = 0.08].
2.5. Assessing E. coli meta-analyses by topic and region
Figure 5 graphs the number of published E. coli meta-analyses ordered by topic from the 
three world regions. Published outputs from the Americas were higher across the topics than 
Europe and Australasia, but when regionally combined, the higher American productivity 
was not significant (one-way ANOVA: P = 0.62). However, when ordered by topic and ana-
lyzed by one-way ANOVA and the Holm-Sidak post-test, CIP productivity was significantly 
higher than EPI (P = 0.005) and ENV (P = 0.003) but not between EPI and ENV (P = 0.63).
2.6. Assessing E. coli meta-analyses by region
Figure 6 shows the number of published meta-analyses which was standardized by region. This 
figure shows low meta-analysis outputs in the years 2000–2010 from Europe and Australasia 
compared to the moderate American outputs in the same period. The last 5 years (2011–2016) 
showed high American output compared to the moderate number of publications from Europe 
and Australasia. Figure 7 shows meta-analysis productivity of the three regions standardized 
by year. Per year output of published meta-analyses on E. coli in the first 4 years of the twenti-
eth century was zero for Australasia but moderate for Europe and the Americas. This produc-
tivity declined in the following 4 years (2005–2010) for all regions then shot back up to good 
productivity in between 2011 and 2016. Thus, comparing Figures 6 and 7, we observed higher 
meta-analysis productivity in the Americas per region than that per year. Between 2011 and 
2016, Europe and Australasia had higher meta-analysis productivity when standardized by 
year than that by region. The unadjusted values from Figures 6 and 7 were subjected to statisti-
cal comparison (one-way ANOVA, Holm-Sidak post-test) that combined the data of 16 years. 
Results showed significantly higher number of published outputs from the Americas than 
Europe (P = 0.003) and Australasia (P = 0.002) but not between the latter two (P = 0.89).
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2.7. Assessing E. coli meta-analyses by clinical syndrome
Figure 8 shows the standardized number of meta-analyses from the three regions catego-
rized under the four syndromes. This graph shows American predominance in ENT and REN 
meta-analysis research compared to the two other regions. Between these two syndromes, 
ENT had more than twice the output compared to REN. SEP and MUL outputs were flat 
from all regions. Figure 9 shows minimal output of REN and ENT meta-analyses between 
2000 and 2010 compared to SEP and MUL researches, which were considerably higher in the 
same time span. Between 2011 and 2016, REN and ENT outputs were up to three times higher 
than SEP and MUL meta-analyses. The unadjusted values from Figure 9 of the combined data 
of 16 years showed non-significant associations between the syndromes over time (one-way 
ANOVA: P = 0.20).
2.8. Summary of E. coli meta-analysis publication outputs
Based on the three topics analyzed, increase of CIP meta-analyses indicates a priori increase 
in the number of primary studies (which are requisite to meta-analysis) in a span of 
16 years. This increase has probably to do with focus on treating E. coli infections given 
the infrastructure in laboratories that enable such researches. Table 1 shows that in terms 
of region, leadership of the Americas, specifically the USA in E. coli meta-analysis research 
seem to have been unchallenged since the turn of the twentieth century. Even when E. coli 
publication outputs were low between 2000 and 2010, the Americas still dominated over 
Europe and Australasia. This domination is best interpreted in three contexts: (i) only 
three countries comprise the Americas compared to 10 and eight for the other two regions 
(Figure 4 and Table 1). (ii) Table 1 shows the USA output in meta-analysis to be twice that of 
Canada and eight times that of Brazil. (iii) USA meta-analysis output is four times those of 
Netherlands and Australia, which both lead Europe and Australasia, respectively (Table 1). 
Given the concentration of developing countries in the Asian region where E. coli research 
would be most useful, such outputs are comparatively low and maybe warrant priority in 
future research of this pathogen. Our findings suggest that the region with the capabilities 
to undertake such researches result in higher publication outputs. In terms of outputs per 
year, Australasia and Europe appear to be catching up in productivity in the last 5 years. 
Summing the pattern of the graphs (Figures 4–9), meta-analysis outputs were highest for 
CIP, the Americas and ENT, all between 2011 and 2016 where this time span was involved. 
The lowest meta-analysis outputs were concentrated between 2000 and 2004, specifically 
in the ENV topic and the Australasian region. The year 2000 showed one published meta-
analysis on E. coli [75] and none before that.
2.9. Limitations and strengths
One limitation of this undertaking was that we confined our survey to published E. coli 
research from standard databases. There might have been meta-analyses done in  government 
and university settings on E. coli but were not included in the databases we searched on. 
Another limitation is non-inclusion of gray literature in our survey, which by its nature has 
not been published. However, one strength is that this chapter gave a sense of the direction of 
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E. coli research based on previous publications. Because we used parameters such as region, 
year, topic and clinical syndrome, this provided some measure of direction as to how E. coli 
research was conducted and what areas in this discipline need focusing in the future.
2.10. Conclusions
E. coli meta-analyses in this survey varied in many aspects, not only in geography but also 
in the topic and syndrome. Most salient was variability in the outcomes and approaches. For 
outcomes, they ranged from presence to absence of associations and effectivity or absence of 
treatment. The point of these outcomes is the exposition of magnitude where influence of fac-
tors may be great or minimal; all these having been statistically treated. For approaches, sub-
jects range from humans to non-human animals and even plants (fresh  produce). This survey 
of meta-analysis publications indicates areas of discipline that were emphasized and those 
that were not. E. coli research outputs, as in other biomedical disciplines, are increasing at an 
exponential rate. Because of the critical importance of E. coli research findings across popula-
tions and geographical regions, objective evaluation of these primary studies may facilitate 
decision making that impacts upon public health policy. Clinicians, researchers and demog-
raphers in this field would likely benefit from the use and interpretation of meta-analysis. 
The survey in this review delineates a relatively high use of meta-analysis in E. coli research 
in the Americas, where the USA most specifically continues to assert its capability in utilizing 
outputs from primary E. coli studies since the turn of the twentieth century. Of note, the recent 
years also showed increasing use of E. coli meta-analyses from Europe and Australasia. Not 
Europe N Americas N Australasia N
1 Netherlands 4 USA 16 Australia 4
2 UK 3 Canada 8 China 3
3 Denmark 2 Brazil 2 Japan 1
4 Germany 4 Total 26 Iran 1
5 Poland 1 Pakistan 1
6 Italy 6 Bangladesh 1
7 Sweden 1 Turkey 1
8 Greece 1 Philippines 1
9 France 1 Total 13
10 Ireland 1
11 Portugal 1
12 Slovenia 1
Total 26
N: number of published articles; UK: United Kingdom; USA: United States of America.
Table 1. Countries comprising each of the three world regions and published outputs of E. coli research resulting from 
literature searches in PubMed, Science Direct and Google Scholar.
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only do primary studies addressing the same issue had conflicting results, they also varied in 
geography, methodology, and sample size-leading to perceived controversy or uncertainty 
about the pathogenic nature of this organism. Application of systematic statistical approaches 
allowed confirmation that many strains of E. coli cause endpoint diseases. Similar meta-anal-
ysis in the larger sphere of microbiology may have the ability to advance our understanding 
of other emerging and established pathogens.
Of the three E. coli topics this chapter has covered, ENV studies have garnered the least atten-
tion over the last 16 years compared to EPI and CIP. Even less in magnitude are genetic/
genomic issues which were barely covered in this chapter given the paucity of primary stud-
ies on this topic. If the past is any guide to future prospects, then it would be judicious to 
forego what is fashionable in research and begin addressing issues that impact upon the lives 
of those affected/infected with E. coli. The tide of geopolitical forces has given rise to mass 
migration and exponential increase in world population at the cost of environmental degrada-
tion. These global features define regions most susceptible to the ravages of E. coli infection. 
Thus, it seems most suited to emphasize the future in E. coli research along these scales in 
order of priority, ENV, EPI and CIP. However, this is not to de-prioritize the genomic/pro-
teomic approaches as it forms the foundation upon which E. coli research achieves milestones. 
The future of genomic epidemiology is detailed in Eppinger and Cebula’s paper where they 
focus on the EHEC serotype [84].
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Appendices and nomenclatures
E. coli Escherichia coli
PRISMA Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses
ISI Institute of Scientific Information
OR Odds ratio
CI Confidence interval
CIP Clinical/intervention/preventive
EPI Epidemiological
ENV Environmental
ENT Enteric or diarrheal
REN Renal; which includes the term uremic
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